Page last updated: 2024-12-10

1,2-bis(10,12-tricosadiynoyl)phosphatidylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 1,2-Bis(10,12-tricosadiynoyl)phosphatidylcholine: A Synthetic Phospholipid for Research

**1,2-Bis(10,12-tricosadiynoyl)phosphatidylcholine (DC8PC)** is a synthetic phospholipid with two long, unsaturated fatty acid chains containing diyne moieties (two triple bonds) at the 10th and 12th positions. This unique structure makes it a valuable tool in various research areas, particularly in studying membrane dynamics and biophysics.

**Importance in Research:**

1. **Membrane Dynamics and Fluidity:** DC8PC acts as a **molecular ruler** in membrane studies. Its diyne moieties have specific absorption properties that allow researchers to probe membrane properties like:
* **Lateral diffusion:** The diyne groups can be excited with UV light, causing them to fluoresce. This fluorescence can be measured to track their movement within the membrane, providing information about lateral diffusion rates.
* **Membrane fluidity:** Changes in the fluidity of the membrane can affect the mobility of DC8PC molecules. Researchers can monitor these changes through fluorescence anisotropy measurements, which reflect the rotational freedom of the probes.

2. **Membrane Structure and Organization:** DC8PC can be used to study:
* **Lipid packing:** The unique structure of DC8PC allows it to interact with other lipids in specific ways, influencing lipid packing and membrane organization.
* **Domain formation:** DC8PC can help identify and characterize lipid domains or rafts within membranes, which are enriched in specific lipids and proteins and play crucial roles in cellular processes.

3. **Lipid-Protein Interactions:** DC8PC can be incorporated into membranes to study:
* **Protein association with specific lipid domains:** This can provide insights into how proteins interact with membranes and how they are localized within different cellular compartments.
* **Effects of lipids on protein function:** By modifying the lipid composition of membranes with DC8PC, researchers can study how lipid changes influence the activity and behavior of membrane-bound proteins.

4. **Drug Delivery and Nanocarriers:** DC8PC is a versatile molecule for creating liposomes, which are nano-sized vesicles used for:
* **Drug delivery:** Liposomes containing DC8PC can encapsulate and transport drugs to specific targets within the body, improving drug efficacy and reducing side effects.
* **Nanocarrier design:** DC8PC can be incorporated into nanocarriers to tune their properties, such as stability, targeting ability, and drug release kinetics.

**Overall, 1,2-Bis(10,12-tricosadiynoyl)phosphatidylcholine (DC8PC) is a powerful tool for studying membrane dynamics, structure, and interactions. Its unique properties make it invaluable for advancing research in diverse fields, including biophysics, cell biology, and drug delivery.**

1,2-bis(10,12-tricosadiynoyl)phosphatidylcholine: constituent of lipid tubules [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080938
SCHEMBL ID415281
MeSH IDM0152570

Synonyms (15)

Synonym
dc(8,9)pc
1,2-bis(10,12-tricosadiynoyl)phosphatidylcholine
1,2-ditricosa-10,12-diynoyl-sn-glycero-3-phosphocholine
1,2-bis(tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine
3,5,9-trioxa-4-phosphadotriaconta-19,21-diyn-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxo-10,12-tricosadinyl)oxy)-, hydroxide, inner salt, 4-oxide, (r)-
1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine
76078-28-9
1,2-btpc
[(2r)-2,3-di(tricosa-10,12-diynoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
SCHEMBL415281
DTXSID40226969
23:2 diyne pc [dc(8,9)pc]
23:2 diyne pc [dc(8,9)pc], 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine, powder
(r)-2,3-bis(tricosa-10,12-diynoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate
BP-28327
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (19.23)18.7374
1990's10 (38.46)18.2507
2000's5 (19.23)29.6817
2010's6 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]